Villaruel, Rodgelyn C.
HRN: 09-51-33 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/18/2022
CO-AMOXICLAV 625MG (TAB)
07/18/2022
07/26/2022
PO
625mg
Q12
S/P CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes